Stocks
Novartis (NVS) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 30 914 | 14 682 | 18 255 | 20 715 | 22 987 | 22 399 | ||
| Changes by years, y/y, % | +80% | -53% | +24% | +13% | +11% | +6.0% | |||
Novartis. EBITDA US GAAP, bln rub
Novartis. EBITDA US GAAP, changes, %
Novartis. EBITDA US GAAP, sum by quarters, bln rub
Novartis (NVS) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 6 076 | 5 841 | 5 073 | 5 410 | 5 936 | 22 399 | |
| Changes by years, y/y, % | +16% | +4% | -2% | -7% | -2% | |||
| Changes by quarters, q/q, % | +4% | -4% | -13% | +7% | +10% | |||
